News Focus
News Focus
icon url

MasterChi

03/31/20 11:46 AM

#4579452 RE: MasterChi #4579326

AVXL up 10%. $12pt-Multiple-Sclerosis-&-Parkinson. Parkinson data any time now.

Anavex Life Sciences to Webcast 2020 Annual Meeting of Shareholders for April 7th
https://finance.yahoo.com/news/anavex-life-sciences-webcast-2020-120010671.html

Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Multiple Sclerosis (MS)
https://finance.yahoo.com/news/anavex-life-sciences-announces-publication-120010207.html

Anavex Life Sciences Announces Fast Track Designation Granted by U.S. FDA for ANAVEX®2-73 (blarcamesine) Clinical Development Program for the Treatment of Rett Syndrome
https://finance.yahoo.com/news/anavex-life-sciences-announces-fast-120010290.html




icon url

MasterChi

03/31/20 1:19 PM

#4579547 RE: MasterChi #4579326

AVXL cheap at 3.08 PT $12 Parkinson’s disease & MS. Parkinson data any time now.

Anavex Life Sciences to Webcast 2020 Annual Meeting of Shareholders for April 7th
https://finance.yahoo.com/news/anavex-life-sciences-webcast-2020-120010671.html

Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (blarcamesine) in Multiple Sclerosis (MS)
https://finance.yahoo.com/news/anavex-life-sciences-announces-publication-120010207.html

Anavex Life Sciences Announces Fast Track Designation Granted by U.S. FDA for ANAVEX®2-73 (blarcamesine) Clinical Development Program for the Treatment of Rett Syndrome
https://finance.yahoo.com/news/anavex-life-sciences-announces-fast-120010290.html